Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Fluids and Barriers of the CNS

Fig. 3

From: Disruption of the hippocampal and hypothalamic blood–brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate

Fig. 3

Effect of diet and topiramate on metabolism-related hormones. Serum samples collected from LF diet + saline (n = 10), LF diet + TPM (n = 11), HF diet + saline (n = 8), and HF diet + TPM (n = 8). Serum was measured for a ghrelin, b glucose-dependent insulinotropic peptide, GIP, c glucagon-like peptide-1, GLP-1, d glucagon, e insulin, f leptin, g plasminogen activator inhibitor-1, PAI-1, and h resistin. Ghrelin showed a significant decrease after HF-feeding, while GIP, insulin, and leptin showed a significant increase. Topiramate treatment had no significant effect at either low- or high-fat feeding. Values are expressed as mean ± SD. Significance was determined by a one-way analysis of variance followed by Newman–Keuls post-test between HF vs. LF, LF vs. LF TPM, and HF vs. HF TPM. *p < 0.05; **p < 0.01; #p < 0.001

Back to article page